●researcherExplicit cyclization-site encoding and Bayesian multi-property guidance offer a more structured alternative to adapting linear peptide generative models for cyclic drug design.
●healthWorth watching for cyclic peptide drug discovery pipelines where stability and binding affinity improvements over linear peptides are clinically relevant.